ViiV Seeks Speedy EMA Review For Last-Resort HIV Drug

US Filing For Fostemsavir Expected This Year

Cells_HIV
Fostemsavir is for HIV patients who have become resistant to other treatments • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Europe

More from Geography